Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

LENZ Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. LENZ Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($112.2M and $110.1M). Tonix Pharmaceuticals Holding Corp. has the higher net margin (−548.6% vs −586.7%) and the lower return on invested capital (−224.5% vs 0.00%). Across the 16 metrics below, LENZ Therapeutics, Inc. leads on 9 and Tonix Pharmaceuticals Holding Corp. on 7.

Valuation

Metric LENZ TNXP Biotechnology median
P/E n/m n/m 8.50
P/S 4.78 3.45 9.71
P/B 0.47 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.85 0.42 0.64
EV/Sales (5.36) (2.35) 9.21
Earnings yield (125.08%) (219.31%) (33.15%)
Free cash flow yield (111.53%) (157.36%) (25.50%)

Profitability

Metric LENZ TNXP Biotechnology median
Gross margin 93.69% 83.83% 65.16%
Operating margin (631.70%) (568.43%) 0.00%
Net margin (586.74%) (548.64%) 0.00%
Free cash flow margin (532.80%) (543.29%) 0.00%
Return on equity (59.21%) (81.82%) (56.36%)
Return on assets (55.52%) (72.34%) (48.04%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric LENZ TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 6.02%
EPS growth (last fiscal year) (21.79%) 91.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 6.61 4.72
Net debt to EBITDA 3.22 1.68 0.96

Dividend

Metric LENZ TNXP Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric LENZ TNXP Biotechnology median
Market cap 112.17m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack